Anti-PP4C/ PPP4C/ PP-X monoclonal antibody

Anti-PP4C/ PPP4C/ PP-X antibody for FACS & in-vivo assay

Target products collectionGo to PPP4C/PPP4C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2265-Ab-1/ GM-Tg-hg-MP2265-Ab-2Anti-Human PPP4C monoclonal antibodyHuman
GM-Tg-rg-MP2265-Ab-1/ GM-Tg-rg-MP2265-Ab-2Anti-Rat PPP4C monoclonal antibodyRat
GM-Tg-mg-MP2265-Ab-1/ GM-Tg-mg-MP2265-Ab-2Anti-Mouse PPP4C monoclonal antibodyMouse
GM-Tg-cynog-MP2265-Ab-1/ GM-Tg-cynog-MP2265-Ab-2Anti-Cynomolgus/ Rhesus macaque PPP4C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2265-Ab-1/ GM-Tg-felg-MP2265-Ab-2Anti-Feline PPP4C monoclonal antibodyFeline
GM-Tg-cang-MP2265-Ab-1/ GM-Tg-cang-MP2265-Ab-2Anti-Canine PPP4C monoclonal antibodyCanine
GM-Tg-bovg-MP2265-Ab-1/ GM-Tg-bovg-MP2265-Ab-2Anti-Bovine PPP4C monoclonal antibodyBovine
GM-Tg-equg-MP2265-Ab-1/ GM-Tg-equg-MP2265-Ab-2Anti-Equine PPP4C monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2265-Ab-1/ GM-Tg-hg-MP2265-Ab-2; GM-Tg-rg-MP2265-Ab-1/ GM-Tg-rg-MP2265-Ab-2;
GM-Tg-mg-MP2265-Ab-1/ GM-Tg-mg-MP2265-Ab-2; GM-Tg-cynog-MP2265-Ab-1/ GM-Tg-cynog-MP2265-Ab-2;
GM-Tg-felg-MP2265-Ab-1/ GM-Tg-felg-MP2265-Ab-2; GM-Tg-cang-MP2265-Ab-1/ GM-Tg-cang-MP2265-Ab-2;
GM-Tg-bovg-MP2265-Ab-1/ GM-Tg-bovg-MP2265-Ab-2; GM-Tg-equg-MP2265-Ab-1/ GM-Tg-equg-MP2265-Ab-2
Products NameAnti-PPP4C monoclonal antibody
Formatmab
Target NamePPP4C
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PPP4C benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PP4C/ PPP4C/ PP-X VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002501human PPP4C Lentivirus particle
    ORF Viral VectorpGMLP002501human PPP4C Lentivirus plasmid
    ORF Viral VectorpGMLPm000665mouse Ppp4c Lentivirus plasmid
    ORF Viral VectorvGMLPm000665mouse Ppp4c Lentivirus particle


    Target information

    Target IDGM-MP2265
    Target NamePPP4C
    Gene ID5531,56420,171366,708510,489947,101101530,540398,100064118
    Gene Symbol and Synonyms1110002D08Rik,PP-X,PP4,PP4C,PPH3,PPP4,PPP4C,PPX
    Uniprot AccessionP60510,Q5BJ92,A6H772
    Uniprot Entry NamePP4C_HUMAN,PP4C_RAT,PP4C_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000149923
    Target ClassificationN/A

    The target: PPP4C, gene name: PPP4C, also named as PP-X, PP4, PP4C, PPH3, PPP4, PPX. Enables protein serine/threonine phosphatase activity. Involved in regulation of double-strand break repair via homologous recombination. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.